GSME Raises $35M Series B to Advance AI and Semiconductor Services
Meta description: GS Microelectronics secures $35 million Series B funding led by Maverick Silicon to expand AI-driven chip design and […]
Meta description: GS Microelectronics secures $35 million Series B funding led by Maverick Silicon to expand AI-driven chip design and […]
Meta description: Consolidation in the medical device sector is limiting acquisition opportunities for startups, raising concerns for investors and long-term
Meta description: Apella secures $80 million in Series B funding to expand its ambient AI hospital platform, backed by major
Meta Description: Major Medical Devices secures a key strategic investment from TCA Venture Group to fast-track its next-generation abdominal aortic
Swissmedic has announced an extension of the therapeutic indication for Jaypirca®, a development that could impact clinical practice and regulatory
On January 10, 2026, Swissmedic issued an official recall notice regarding specific batches of Ringerfundin B. Braun Infusionslösung. This recall
On January 10, 2026, Swissmedic issued an announcement concerning the recall of designated batches of Esomeprazol MUT Sandoz gastro-resistant tablets.
Swissmedic, the Swiss agency responsible for the authorisation and supervision of therapeutic products, recently approved an extension for the therapeutic
Swissmedic has issued a temporary marketing authorization for Sevelamercarbonate Salmon Pharma 800 mg film-coated tablets in German packaging. This development
Swissmedic has announced a significant change in packaging requirements for certain veterinary medicinal products. Starting January 1, 2026, it will